0 results for 'Richards Layton Finger PA'
Poison Pill Not Preclusive in $123 Mil. BioClinica Merger
The Delaware Court of Chancery has denied a motion by shareholders of Pennsylvania-based BioClinica Inc. to expedite their lawsuit against the company, holding that the company did not adopt preclusive deal protection measures when it agreed to a $123 million buyout from JLL Partners Inc.Great Recession Leaves Its Mark on Del. Legal Market
A recent survey of law firms found that more than 75 percent believe that pricing pressure, alternative fee arrangements and efficiency measures will remain part of the legal business even after the Great Recession has faded to a painful memory.Mitigating Financial Adviser Conflicts With Second Adviser
Financial adviser conflicts, whether arising from prior relationships or from the financial adviser's interest in providing buy-side financing, have been a focus in M&A litigation for several years.Strine Orders Dell to Hold October Shareholder Meeting
Delaware Court of Chancery Chancellor Leo E. Strine Jr. has ordered computer maker Dell Inc. to hold its annual shareholder meeting October 17.Reed Smith Hires Former Senator Roth
In a hiring coup for Pittsburgh-based Reed Smith, former U.S. Sen. William V. Roth Jr. will join the firm and expects to tap into the contacts he amassed in taxes, trade, financial services and foreign policy in more than three decades representing the state of Delaware in Congress. Roth, who lost his re-election bid last November, will work in Reed Smith's Wilmington and Washington, D.C., offices.Poison Pill Not Preclusive in $123 Mil. BioClinica Merger, Chancery Court Rules
The Delaware Court of Chancery has denied a motion by shareholders of BioClinica Inc. to expedite their lawsuit against the company, holding that the company did not adopt preclusive deal protection measures when it agreed to a $123 million buyout from JLL Partners Inc. The court's decision means that any trial will not likely start until after the merger's expected completion date of March 11.Circon Shareholder Settlement Including $800,000 in Legal Fees Approved
Circon Corp., a medical device maker, won approval for a settlement of lawsuits brought by shareholders who claimed company executives looked out for their own best interests in fighting off a $235 million takeover bid by U.S. Surgical Corp. In the settlement, Circon agreed to open itself up for bidders after fending off U.S. Surgical and pay $800,000 in legal fees shareholders racked up in suits against the company.A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now
A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster
Brought to you by HaystackID
Download Now
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now